Tepkinly 4 mg/0.8 ml concentrate for solution for injection
*Company:
AbbVie LimitedStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
Updated on 15 April 2024
File name
Tepkinly_PIL_4mg-0.8ml_ePI_April 24.pdf
Reasons for updating
- Addition of information on alternative format leaflets
Free text change information supplied by the pharmaceutical company
Other sources of Information - updated to include the URL: www.tepkinly.eu and the relevant QRD code.
Updated on 09 November 2023
File name
Tepkinly_SmPC_4mg-0.8ml_MAA_Sept 23.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
New Product registration
Updated on 09 November 2023
File name
Tepkinly_SmPC_4mg-0.8ml_MAA_Sept 23.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
New Product registration
Updated on 09 November 2023
File name
Tepkinly_PIL_4mg-0.8ml_MAA_Sept 23.pdf
Reasons for updating
- New PIL for new product
Free text change information supplied by the pharmaceutical company
New product registration.
File name
12842_Tepkinly_Card_SEPT23_LR6.pdf
Reasons for updating
- Add New Doc